|
|
|
| home > pmps > current issue |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
|
Industry Insight
Randice Altschul examines articles in this issue of PMPS, looking at mechanical seals, the difficulties of ageappropriate packaging, and how not effectively planning designs can lead to delays in the production line.
|
|
|
|
|
|
Managing Artwork Compliance
Improvements in Artwork Management Ensure Compliance for Pharmaceutical Manufacturers
Paul Goldberg at Loftware stresses the importance of artwork management and how choosing the right solution per company to address their artwork complexities can be hugely beneficial in the long term.
|
|
|
|
|
Examining Orally Disintegrating Tablets
A Comparative Study of Directly Compressible Orally Disintegrating Tablet Plaforms
Orally disintegrating tablets (ODTs) prove to be particularly beneficial for the elderly and young children, for whom compliance can be difficult to achieve. Omya’s Dr Carolina Diaz Quijano delves further into the advantages of ODTs and reviews the progress in their development thus far.
|
|
|
|
Developing Future Production
Goals for Greater Tablet Production
The pressure is on for tablet manufacturers to mass produce drugs while maintaining quality and also keeping costs down. Alex Bunting at I Holland introduces multi-tip tooling as a more efficient way to produce tablets.
|
|
|
|
|
The Dangers of Leaving Packaging Quality to Chance
Perfect Packaging
Schlafender Hase’s Marc Chaillou explains why, in an age of automation, a manual approach to packaging and labelling is not ideal for meeting regulatory requirements and how technology should be embraced instead.
|
|
|
|
|
Best Practice Throughout the Supply Chain
Improving the Chain’s Efficiency
Christian Taylor at Zetes advises on how best to approach the quickly impending Falsified Medicines Directive, using serialisation in particular as a means for bettered traceability and real-time visibility.
|
|
|
|
The Supply Chain of the Near Future
From Governance to Provenance
Supply chain management has become about more than just tracking the product’s location and arrival; greater emphasis is being placed on addressing blind spots in the chain to improve product authenticity. Chris Sultemeier at rfxcel discusses the ways in which this can be achieved.
|
|
|
|
Making a Big Difference to Small Patient Populations
The Heart of Healthcare
Rare diseases are becoming increasingly prominent as a focal point for the industry, which begs the need for specialist approaches towards the distribution of their corresponding medicines. Jonathan Chapper at CHAPPER healthcare reviews the pros and cons of investing in this arena.
|
|
|
|
|
|
End of the Line
Serialisation: Are you Ready?
PMPS’s Industry Advisor, Randice Altschul, looks into the latest developments and regulations surrounding serialised authentication as companies across the industry strive to combat drug counterfeiting.
|
|
|
|
|
Opportunities for Orally Inhaled Drug Products
Embracing Spray Drying Strategies
One primary benefit of orally inhaled drugs is that they are recognised to be a more effective method for regional and systemic delivery. Adita R Das PhD, MBA at Recipharm examines how the challenges in inhaled drug development are well worth the effort and technicalities.
|
|
|
|
Spotlight: 3M
Inhalation Drug Delivery: Going Generic, Getting Connected
The competitive nature of pharmaceutical markets, and the growing need to be set apart from the crowd, has highlighted the need for an established and dependable partner to keep ahead of the curve.
|
|
|
|
Spotlight: H&T Presspart
Dose Counters and Indicators: A Real Patient Need
Chronic lung disorders are responsible for millions of deaths each year. Manufacturers are working towards more efficient solutions to improve patient quality of life.
|
|
|
|
Event Preview
Connected to Inhalation
Take an exclusive look at what is to come in the annual Respiratory Drug Delivery Conference, taking place in Lisbon, Portugal, this May.
|
|
|
|
|
Collaboration to Achieve Compliance
Preparing Parallel Importers for Post EU-FMD Success
Ian Haynes at Excellis Europe guides parallel importance through the challenges and necessary considerations to be tackled ahead of the Falsified Medicines Directive.
|
|
|
|
Biologic Medicines and Patient Centricity
A New Phase of Hope
Biologic medicines are bringing great change to the industry and are considered to be a driver in personal care. Justin Schroeder at PCI Pharma Services explores the new freedoms biologics bring to the market.
|
|
|
|
Clinical Trial Packaging
Supply Forecast
Wasdell Group’s Colin Newbould outlines the numerous considerations that need to be made surrounding packaging clinical supplies, particularly as the industry continuously shifts towards a more standardised approach.
|
|
|
|
Introducing Mechanical Seals
Contamination Control
Mechanical seals do not get the recognition they deserve, states John Smiddy at AESSEAL, who details how their adoption could help companies meet compliance requirements and ensure return on investment.
|
|
|
|
|
Age Considerations in Pharmaceuticals
A Closer Look at Child-Resistant Packaging
Cedric Dujardin at the Belgian Packaging Institute (IBE-BVI) highlights the importance of testing child-resistant packaging to ensure that classification, labelling, and packaging regulations are being met.
|
|
|
|
Gaining Child-Resistant Certification Planning
Safe, Secure, and Simple
Despite the decades of difference between senior citizens and young children, requirements for packaging overlap. Dane Whitehurst at Burgopak examines how packaging design necessitates detailed testing and examination of the user responses for safety and usability.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000L
Biotechpharma UAB, a leading biopharmaceutical Contract Development and
Manufacturing Organization (CDMO), today announced further expansion of
its fermentation capacity to 5,000L along with an additional state of
the art process development laboratory, investing more than €50 million
in the expansion.
More info >> |
|
 |
White Papers |
 |
|
Working Towards a Standardised Identification Solution
PCI Pharma Services
The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >> |
|
 |
Industry Events |
 |
ASGCT 22nd Annual Meeting
29 April - 2 May 2019, Washington Hilton, Washington, D.C
The 2019 ASGCT Annual Meeting is expected to be the largest in Society
history, eclipsing the mark set by the 2018 meeting just last year. Join more
than 3,500 researchers, clinicians, advocates, and industry leaders in
discovering the latest science and technology surrounding gene and cell
therapy.
More info >> |
|
|
